CASI Pharmaceuticals Inc (CASI)
5.74
+0.19
(+3.42%)
USD |
NASDAQ |
Nov 14, 16:00
5.46
-0.28
(-4.88%)
After-Hours: 18:02
CASI Pharmaceuticals Profit Margin (Quarterly): -175.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -175.0% |
| March 31, 2024 | -279.5% |
| December 31, 2023 | -88.09% |
| September 30, 2023 | -52.44% |
| June 30, 2023 | -104.3% |
| March 31, 2023 | -71.99% |
| December 31, 2022 | -128.0% |
| September 30, 2022 | -50.93% |
| June 30, 2022 | -89.58% |
| March 31, 2022 | -94.86% |
| December 31, 2021 | -61.16% |
| September 30, 2021 | -126.0% |
| June 30, 2021 | -96.98% |
| March 31, 2021 | -242.0% |
| December 31, 2020 | -294.5% |
| September 30, 2020 | -399.6% |
| June 30, 2020 | -325.5% |
| March 31, 2020 | -247.8% |
| December 31, 2019 | -929.5% |
| September 30, 2019 | -354.9% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -8.73K% |
| March 31, 2015 | -7.60K% |
| December 31, 2014 | -6.73K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | -53.85% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-929.5%
Minimum
Dec 2019
-50.93%
Maximum
Sep 2022
-203.0%
Average
-126.0%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| Zai Lab Ltd | -79.87% |
| China SXT Pharmaceuticals Inc | -- |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -88.87% |
| Return on Assets | -40.37% |
| Return on Invested Capital | -65.07% |
| Gross Profit Margin (Quarterly) | 51.95% |
| Operating Margin (Quarterly) | -240.1% |
| Return on Net Operating Assets | -79.43% |